Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 04:34 PM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Stock Picks » Strong Buy: HLCS - Helicos BioSciences Corp. (NASDAQ)



Reply
 
Thread Tools Search this Thread
Old 08-29-2009, 10:36 AM   Nav to Top  #21
SupremeFire
Junior Trader
 
SupremeFire's Avatar
 
Join Date: Apr 2009
Location: Midlands, UK
Posts: 15
Favorites: HLCS / SXX / KFN
Rep Power: 145
Reputation: 200
SupremeFire has a spectacular aura aboutSupremeFire has a spectacular aura aboutSupremeFire has a spectacular aura about
Default

Yep, I'd also like to thank both Etiennester and Money123. Rest in the knowledge that you made a number of us very happy, and financially, slightly better off.

What are peoples thoughts on Helicos for the week ahead?
SupremeFire is offline   Rate this post Yes | No Reply With Quote
Old 08-31-2009, 10:04 AM   Nav to Top  #22
Miles
Seeking Bottoms
 
Miles's Avatar
 
Join Date: Mar 2009
Location: Vancouver
Posts: 754
Favorites: LVS, FAS/FAZ, POT
Rep Power: 308
Reputation: 3520
Miles has a reputation beyond reputeMiles has a reputation beyond reputeMiles has a reputation beyond reputeMiles has a reputation beyond reputeMiles has a reputation beyond reputeMiles has a reputation beyond reputeMiles has a reputation beyond reputeMiles has a reputation beyond reputeMiles has a reputation beyond reputeMiles has a reputation beyond reputeMiles has a reputation beyond repute
Did I help?
Send a message via AIM to Miles Send a message via Skype™ to Miles
Shocked

Whoa HLCS is the gift that keeps on giving. Anyone taking profits/free shares on this rocket yet?
__________________
Please note that all information on securities I provide is merely my own opinion and any advice given is purely speculative and should not under any circumstances be considered investment advice. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation.
Miles is offline   1 thumbs up / 0 thumbs down. Rate this post Yes | No Reply With Quote
Old 08-31-2009, 11:15 AM   Nav to Top  #23
andre3k1
Senior Trader
 
andre3k1's Avatar
 
Join Date: Aug 2009
Location: MIAMI
Posts: 110
Rep Power: 149
Reputation: 309
andre3k1 is a jewel in the roughandre3k1 is a jewel in the roughandre3k1 is a jewel in the roughandre3k1 is a jewel in the rough
Default

look at HLCS go! plowed right through 2.50 up to 2.80 at the moment.
__________________
follow me. . . .
http://twitter.com/BullishBEAR (for stock talk)
http://twitter.com/andre3k1 (personal)
andre3k1 is offline   Rate this post Yes | No Reply With Quote
Old 08-31-2009, 11:46 AM   Nav to Top  #24
Longshot
Trader
 
Longshot's Avatar
 
Join Date: Aug 2009
Location: Chicago
Posts: 72
Favorites: ICO, CMED, USG
Rep Power: 141
Reputation: 163
Longshot has a spectacular aura aboutLongshot has a spectacular aura about
Default

UP to 3.40!!!

Good call Money123 and others!

Longshot is offline   Rate this post Yes | No Reply With Quote
Old 09-01-2009, 07:05 PM   Nav to Top  #25
victor420
Junior Trader
 
victor420's Avatar
 
Join Date: Jun 2009
Location: Charlotte
Posts: 24
Rep Power: 135
Reputation: 10
victor420 is on a distinguished road
Default

Did anyone book profits or sell this one yet? or is it likely to go higher in the next few months?
victor420 is offline   Rate this post Yes | No Reply With Quote
Old 09-01-2009, 07:14 PM   Nav to Top  #26
andre3k1
Senior Trader
 
andre3k1's Avatar
 
Join Date: Aug 2009
Location: MIAMI
Posts: 110
Rep Power: 149
Reputation: 309
andre3k1 is a jewel in the roughandre3k1 is a jewel in the roughandre3k1 is a jewel in the roughandre3k1 is a jewel in the rough
Default

Originally Posted by victor420 View Post
Did anyone book profits or sell this one yet? or is it likely to go higher in the next few months?
yeap, yesterday. in at 2.64 out at 3.50 in about 15 mins thanks to Miles

i was never in it for the long run tho
__________________
follow me. . . .
http://twitter.com/BullishBEAR (for stock talk)
http://twitter.com/andre3k1 (personal)
andre3k1 is offline   Rate this post Yes | No Reply With Quote
Old 09-03-2009, 10:35 AM   Nav to Top  #27
victor420
Junior Trader
 
victor420's Avatar
 
Join Date: Jun 2009
Location: Charlotte
Posts: 24
Rep Power: 135
Reputation: 10
victor420 is on a distinguished road
Default

Any comments on news today? --> http://www.businesswire.com/portal/s...09&newsLang=en

Last edited by Miles; 09-03-2009 at 11:01 AM.. Reason: it helps if you post a link to the news (I did it for you)
victor420 is offline   Rate this post Yes | No Reply With Quote
Old 09-08-2009, 08:27 AM   Nav to Top  #28
hlkhl
Junior Trader
 
hlkhl's Avatar
 
Join Date: Jul 2009
Location: singapore
Posts: 12
Favorites: hlcs avii anx aria
Rep Power: 136
Reputation: 62
hlkhl will become famous soon enough
Default

good news.


Helicos Sells Multiple HeliScope™ Sequencers to RIKEN Institute
Written by webmaster
Monday, 07 September 2009 23:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (NASDAQ:HLCS) today announced that the RIKEN Yokohama Institute Omics Science Center (OSC) has agreed to purchase four Helicos&# 482; Genetic Analysis Systems. The transaction represents the first multisystem sale of the Helicos system to a large genome center. Shipments are expected to take place in September, with one system remaining in Cambridge to be used in a scientific collaboration between the two parties that began last year.

RIKEN’s OSC recently received funding from the Japanese government to assume the role of the country’s primary national DNA sequencing center. As part of Japan’s renowned RIKEN, the OSC has the unifying objective of developing a multi-purpose, large-scale analysis center to elucidate molecular networks in biological systems. A major component of the national project for the RIKEN OSC is the “Cell Innovation Project”, which is aimed at understanding cell function at the molecular level using next-generation and single-molecule sequencing technologies.

In addition to the sale of systems and reagents, RIKEN and Helicos will continue a scientific collaboration that began in November 2008. The collaborative research plan is designed to enable new insights into cell biology and to explore novel methods to ultimately enable singlecell transcriptome analyses. The OSC Director, Yoshihide Hayashizaki, M.D., Ph.D., will comanage the research plan with Patrice Milos, Ph.D., Helicos Vice President and Chief Scientific Officer.

“Our relationship with the RIKEN OSC led by Dr. Hayashizaki and RIKEN’s commitment to purchase the Helicos systems demonstrates the value of Helicos technology to the scientific community,” explained Helicos President Steve Lombardi. “We’re proud to have such a prestigious institution as our first multi-system genome center customer. Their commitment is further validation of the scientific and commercial importance of single molecule sequencing.”

“The single-molecule sequencing platform developed by Helicos will help accelerate on-going progress in transcriptomics analysis at RIKEN’s OSC,” remarked Dr. Hayashizaki. “The Helicos system offers us the ability to make unbiased measurements of nucleic acids without amplification, to utilize very low starting amounts of nucleic acid, and to generate over 800 million sequences per run, providing accurate and precise measurements. These benefits of single-molecule sequencing to quantitative expression profiling, including measuring the activity of gene regulatory regions, will greatly expand our range of experimental approaches so that we can reveal more of the unknown biology of the genome to the scientific community.”

“RIKEN has been at the forefront of scientific and technological advances that have revolutionized genomic sciences,” stated Patrice Milos. “Our collaboration over the last year, culminating in this multi-unit system acquisition, once again demonstrates the innovation and vision that serves as the RIKEN hallmark. We are honored to continue our work together.”

About Helicos BioSciences

Helicos BioSciences is a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets. Helicos' proprietary True Single Molecule Sequencing (tSMS)™ technology allows direct measurement of billions of strands of DNA, enabling scientists to perform experiments and ask questions never before possible. Helicos is a recipient of the $1,000 genome grant and is committed to providing scientists the tools to unlock the era of genomic medicine. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800. For more information, please visit True Single Molecule Sequencing : Helicos BioSciences.

About The Omics Science Center at the RIKEN Yokohama Institute

RIKEN is a Japanese research institute that carries out high-level experimental and research work in a wide range of fields, including physics, chemistry, medical science, biology, and engineering, covering the entire range from basic research to practical applications. RIKEN was first organized in 1917 as a private research foundation and was reorganized in 2003 as an independent administrative institution under the Ministry of Education, Culture, Sports, Science and Technology. RIKEN Omics Science Center is one of 13 research centers in RIKEN and its focus is on developing genome-wide technologies and their applications. w

Certain statements made in this press release that are not based on historical information are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This press release contains express or implied forward-looking statements relating to, among other things, the anticipated commercial and scientific benefits of the sale of the Helicos systems to RIKEN OSC discussed in this press release, and management's plans, objectives and strategies. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond Helicos' control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things, our ability to successfully complete and/or scale the manufacturing and commercialization process for the Helicos Genetic Analysis System; our history of operating losses and ability to achieve profitability; our ability to sustain and scale our manufacturing capabilities; the research and development spending levels of academic, clinical and governmental research institutions and pharmaceutical, biotechnology and agriculture companies who may purchase our Helicos Genetic Analysis System; our reliance on third-party suppliers; competition; changing technology and customer requirements; our ability to operate in an emerging market; market acceptance of our technology; the length of our sales and implementation cycles; our dependence on large contracts for the sale and implementation of our Helicos Genetic Analysis System; failure of our technology and products; our ability to maintain customer relationships and contracts; ethical, legal and social concerns surrounding the use of genetic information; our ability to retain our personnel and hire additional skilled personnel; our ability to manage our growth while operating with limited resources; our ability to control our operating expenses; general economic and business conditions; our ability to obtain capital when desired on favorable terms; and the volatility of the market price of our common stock. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Helicos undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For additional disclosure regarding these and other risks faced by Helicos, see the disclosure contained in Helicos' public filings with the Securities and Exchange Commission.
hlkhl is offline   Rate this post Yes | No Reply With Quote
Old 09-08-2009, 09:35 AM   Nav to Top  #29
GregTheGreatONE
Senior Trader
 
GregTheGreatONE's Avatar
 
Join Date: Sep 2009
Location: Hartford, CT
Posts: 107
Favorites: GE, RTK, LVS
Rep Power: 141
Reputation: 105
GregTheGreatONE will become famous soon enoughGregTheGreatONE will become famous soon enough
Default thanks

yes thanks for this one, ive owned this stock for 2 weeks now and its doubled so far and i think this is only the beginning for this company,

last time i checked it was up 27% premarket!
GregTheGreatONE is offline   Rate this post Yes | No Reply With Quote
Old 09-11-2009, 02:09 PM   Nav to Top  #30
victor420
Junior Trader
 
victor420's Avatar
 
Join Date: Jun 2009
Location: Charlotte
Posts: 24
Rep Power: 135
Reputation: 10
victor420 is on a distinguished road
Default

I am in a lot of green with this stock, not sure which way it will go from here. Will it be a stupid move to sell it now before the conference? Any thoughts are thoroughly appreciated!!!
victor420 is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Dividend: ARCC Ares Capital Corp (Nasdaq-Finance) Kordoyn US Stock Picks 0 05-28-2009 08:26 AM
Teton Energy Corp. (Nasdaq:TEC) GreG US Stock Picks 5 05-18-2009 09:23 PM
Buy: ASTI (Ascent Solar Technologies, Inc. - NASDAQ) 6tp US Stock Picks 0 05-08-2009 06:03 PM
Buy: WRES (Warren Resources) Nasdaq chumptochamp US Stock Picks 0 05-06-2009 01:48 PM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On